Xilio Therapeutics
XLO
#9533
Rank
โ‚ฌ36.64 M
Marketcap
0,83ย โ‚ฌ
Share price
-6.56%
Change (1 day)
26.47%
Change (1 year)

Xilio Therapeutics (XLO) - Cash on Hand

Cash on Hand as of September 2024 : โ‚ฌ58.93 Million

According to Xilio Therapeutics's latest financial reports the company has โ‚ฌ58.93 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Xilio Therapeutics - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31โ‚ฌ0.11 B-35.83%
2021-12-31โ‚ฌ0.17 B1018.11%
2020-12-31โ‚ฌ15.64 M-64.13%
2019-12-31โ‚ฌ43.6 M